Results 31 to 40 of about 3,752 (164)

Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup

Case Reports in Medicine, 2012
Purpose. To show the long-term results of intravitreal ranibizumab combined with photodynamic therapy (PDT) for the treatment of polypoidal choroidal vasculopathy (PCV). Methods. We analyzed the progress of two patients for 36 and 58 months, respectively.
Maribel Fernández, María Gil, Francisco Gomez-Ulla, Pablo Charlón   +3 more
doaj   +1 more source

Photodynamic Therapy for Polypoidal Choroidal Vasculopathy [PDF]

Journal of Ocular Pharmacology and Therapeutics, 2010
Dear editor, I read the article by Mori et al [1] with interest. The article reports factors affecting the visual outcome of photodynamic therapy (PDT) for polypoidal choroidal vasculopathy (PCV). I would like to comment about the disadvantages of PDT in PCV. PDT is associated with several disadvantages.
openaire   +2 more sources

Consensus on age‐related macular degeneration course curricula for general ophthalmologists and non‐ophthalmologist clinical staff: A Delphi study

Acta Ophthalmologica, Volume 104, Issue 3, Page e269-e276, May 2026.
Abstract Purpose To define the curriculum content for two interactive learning courses on age‐related macular degeneration (AMD): (1) an advanced course tailored for general ophthalmologists and (2) a basic course for non‐ophthalmologist healthcare staff.
Filip Sommer‐Lind, Yousif Subhi, Anna S. Vergmann, Monica Lövestam‐Adrian, Nis Andersen, Enrico Borrelli, Lasse J. Cehofski, Mads K. Falk, Øystein K. Jørstad, Kai Kaarniranta, Musa Y. Kaya, Morten B. Larsen, Gregor S. Reiter, Miklos Schneider, Henrik Vorum, Jakob Grauslund, VILMA‐AMD Study Group, Anja Bate, Anja Lund, Anssam Al‐Sharmary, Audrone Rimsaite, Charlotte Melsen, Charlotte Mikkelsen, Christoffer Rud Sørensen, Elizabeth Visby, Hanne Roed, Henrik Kemp, Henrik Melsom, Jeanet Lomholt, Jens Lundgaard Andresen, Jesper Skov, Karen Laursen, Kristian Lundberg, Lena Andersen, Lene Bang Jensen, Line Gerken, Line Petersen, Louise Munkholm, Marie Krogh, Mette Borg Madsen, Mikkel Lyngholm, Per Flesner, Pernille Oversø Hansen, Peter Fahmy, Sathuja Prasad, Søren Berndt Hansen, Søren Kromann Abildgaard   +46 more
wiley   +1 more source

Neovascular age‐related macular degeneration without drusen

Acta Ophthalmologica, Volume 104, Issue 3, Page e300-e311, May 2026.
Abstract Purpose To describe the clinical characteristics and 1‐year follow‐up of patients with neovascular AMD (nAMD) without drusen in either eye. Methods This is a multicentre retrospective cohort study in three tertiary referral centres in The Netherlands. We included patients of 55 years or older with nAMD in one or both eyes, without the presence
Marc J. Sirks, Elon H. C. van Dijk, Husein Ghalayini, Somayeh Bazdar, WeiFeng Yu, Suzanne Yzer, José P. Martinez Ciriano, Reinier O. Schlingemann, Roselie M. H. Diederen, Camiel J. F. Boon   +9 more
wiley   +1 more source

One-year outcomes of intravitreal brolucizumab injections in patients with polypoidal choroidal vasculopathy

Scientific Reports, 2022
To evaluate the 1-year visual outcomes and anatomic responses of Japanese patients who received intravitreal brolucizumab (IVBr) injections for polypoidal choroidal vasculopathy (PCV).
Arisa Ito, Maiko Maruyama-Inoue, Yoko Kitajima, Shoko Ikeda, Tatsuya Inoue, Kazuaki Kadonosono   +5 more
doaj   +1 more source

Pregnancy as a risk factor for central serous chorioretinopathy: A systematic review and meta‐analysis

Acta Ophthalmologica, Volume 104, Issue 3, Page 259-266, May 2026.
Abstract Purpose Pregnancy induces significant changes in the body, including increased peripheral and choroidal blood perfusion and an increased systemic corticosteroid level. Here, we systematically reviewed the evidence on pregnancy as a risk factor for developing central serous chorioretinopathy (CSC) and conducted a meta‐analysis to obtain a ...
Nathalie Skovgaard Eriksen, Zainab Fakhril‐din, Riccardo Fasana, Rodrigo Anguita, Elon H. C. van Dijk, Lorenzo Ferro Desideri, Jakob Grauslund, Michael Stormly Hansen, Oliver Niels Klefter, Armin Motaabbed, Line Petersen, Prithvi Ramtohul, Mehmet Cem Sabaner, Osman Savran, Miklos Schneider, Yousif Subhi   +15 more
wiley   +1 more source

Case Report of Optic Disc Drusen with Simultaneous Peripapillary Subretinal Hemorrhage and Central Retinal Vein Occlusion

Case Reports in Ophthalmological Medicine, 2014
A 52-year-old Chinese gentleman presented with right eye floaters and photopsia over one week. His visual acuities were 20/20 bilaterally. Posterior segment examination showed a right eye swollen optic disc and central retinal vein occlusion (CRVO ...
David Zhiwei Law, Francine Pei Lin Yang, Stephen Charn Beng Teoh   +2 more
doaj   +1 more source

Choroidal nevus and polypoidal vasculopathy: case series

International Journal of Retina and Vitreous, 2020
Background To report an association between choroidal nevus and polypoidal choroidal vasculopathy (PCV) in three patients. Case presentation We have encountered 3 isolated patients in our center presenting with subretinal exudation and a choroidal nevus ...
Karlos Ítalo S. Viana, Pedro F. Dalgalarrondo, Zelia Correa, Rodrigo Jorge   +3 more
doaj   +1 more source

Interventions for submacular haemorrhage: A systematic review and network meta‐analysis of controversies—On behalf of the Spanish Vitreo‐Retinal Society (SERV)

Acta Ophthalmologica, Volume 104, Issue 2, Page 139-163, March 2026.
Abstract Purpose This systematic review aims to evaluate and synthesize the existing literature on the interventions used for submacular haemorrhage (SMH), highlighting the controversies and differences in clinical practice. Method A systematic review was conducted following the PRISMA guidelines.
Salvador Pastor‐Idoate, Pablo Redruello‐Guerrero, Laura de Juan Hernández, Gregorio Benites‐Narcizo, Mario Rivera‐Izquierdo, José García‐Arumí, José Carlos Pastor Jimeno   +6 more
wiley   +1 more source

Polypoidal choroidal vasculopathy [PDF]

British Journal of Ophthalmology, 2007
Polypoidal choroidal vasculopathy (PCV) has been recognised for almost two decades. In 1990, Yannuzzi and colleagues first described idiopathic polypoidal choroidal vasculopathy (IPCV) macular disorder—a choroidal vasculopathy that causes haemorrhagic and exudative macular degeneration—in 11 patients.1 The patients had peculiar polypoidal subretinal ...
F. Mori, S. Eguchi
openaire   +2 more sources